Two Sigma Investments’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-38,393
| Closed | -$265K | – | 3596 |
|
2025
Q1 | $265K | Sell |
38,393
-88,905
| -70% | -$613K | ﹤0.01% | 2698 |
|
2024
Q4 | $675K | Buy |
+127,298
| New | +$675K | ﹤0.01% | 2331 |
|
2023
Q4 | – | Sell |
-11,183
| Closed | -$16.3K | – | 3341 |
|
2023
Q3 | $16.3K | Hold |
11,183
| – | – | ﹤0.01% | 2803 |
|
2023
Q2 | $17.6K | Sell |
11,183
-4,200
| -27% | -$6.59K | ﹤0.01% | 2837 |
|
2023
Q1 | $23.5K | Sell |
15,383
-61,467
| -80% | -$94K | ﹤0.01% | 2761 |
|
2022
Q4 | $129K | Buy |
76,850
+29,925
| +64% | +$50.3K | ﹤0.01% | 2413 |
|
2022
Q3 | $58K | Sell |
46,925
-124,672
| -73% | -$154K | ﹤0.01% | 2254 |
|
2022
Q2 | $287K | Buy |
171,597
+25,907
| +18% | +$43.3K | ﹤0.01% | 1977 |
|
2022
Q1 | $358K | Sell |
145,690
-41,721
| -22% | -$103K | ﹤0.01% | 2116 |
|
2021
Q4 | $701K | Buy |
187,411
+93,429
| +99% | +$349K | ﹤0.01% | 1827 |
|
2021
Q3 | $589K | Buy |
93,982
+1,461
| +2% | +$9.16K | ﹤0.01% | 1944 |
|
2021
Q2 | $912K | Sell |
92,521
-195,234
| -68% | -$1.92M | ﹤0.01% | 1723 |
|
2021
Q1 | $2.69M | Buy |
287,755
+222,144
| +339% | +$2.08M | 0.01% | 1122 |
|
2020
Q4 | $315K | Sell |
65,611
-12,095
| -16% | -$58.1K | ﹤0.01% | 1717 |
|
2020
Q3 | $312K | Sell |
77,706
-67,112
| -46% | -$269K | ﹤0.01% | 1569 |
|
2020
Q2 | $665K | Buy |
+144,818
| New | +$665K | ﹤0.01% | 1313 |
|
2018
Q1 | – | Sell |
-24,668
| Closed | -$145K | – | 2408 |
|
2017
Q4 | $145K | Buy |
+24,668
| New | +$145K | ﹤0.01% | 2064 |
|